This topic contains a solution. Click here to go to the answer

Author Question: What causes the chronic microvascular and macrovascular complications of DM? a. Pancreatic ... (Read 44 times)

urbanoutfitters

  • Hero Member
  • *****
  • Posts: 530
What causes the chronic microvascular and macrovascular complications of DM?
 
  a. Pancreatic changes
  b. Hyperglycemia
  c. Ketone toxicity
  d. Hyperinsulinemia

Question 2

A patient is admitted to the medical unit for complications of long-term, poorly controlled type 2 DM. Which of the following would the nurse expect to find in addition to elevated glucose?
 
  a. Atherosclerosis
  b. Metabolic alkalosis
  c. Elevated liver enzymes
  d. Anemia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Hikerman221

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

ANS: B
The underlying cause of the microvascular and macrovascular diseases is related to hyperglyce-mia, not pancreatic changes, ketone toxicity, or hyperinsulinemia.

Answer to Question 2

ANS: A
Macrovascular disease (lesions in large and medium-sized arteries) increases morbidity and mor-tality and increases risk for accelerated atherosclerosis. Acidosis, rather than alkalosis, would oc-cur in this patient. Neither elevated liver enzymes nor anemia would be expected.




urbanoutfitters

  • Member
  • Posts: 530
Reply 2 on: Jun 25, 2018
Thanks for the timely response, appreciate it


adammoses97

  • Member
  • Posts: 337
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

The heart is located in the center of the chest, with part of it tipped slightly so that it taps against the left side of the chest.

For a complete list of videos, visit our video library